By Sabela OjeaTitan Pharmaceuticals declared a 1-for-20 reverse stock split of its common stock. The development-stage biotechnology company on Thursday said the reverse stock split, approved at a special shareholder meeting on Wednesday, is intended to be effective on Jan. 9.

Source: Wall Street Journal December 29, 2023 09:41 UTC